OBJECTIVE: The impact of untreated mild-to-moderate mitral regurgitation (MR) on patients undergoing isolated aortic valve replacement (AVR) is uncertain. The aim of this study is to investigate its long-term effects on outcomes. METHOD: We retrospectively reviewed 193 consecutive patients undergoing isolated AVR between 1993 and 2007. The mean age of the study group was 64+/-12 years, 59% were male and the mean preoperative ejection fraction was 59+/-12%. The pathologic aetiology and degree of MR was determined on preoperative echocardiogram. Patients were stratified into preoperative no/trivial MR (group I; n=134) versus mild-to-moderate MR (group II; n=59). The aetiology of MR in group II was either organic (n=35, 60%) or functional (n=24, 41%). Survival and functional outcome were compared between the two groups and analyses for predictors of adverse events were performed by the Cox proportional hazard model. RESULTS: Operative mortality was 2.6% (n=5). In group II, mean degree of MR significantly decreased from 2.1+/-0.3 to 1.6+/-0.8 during the late period (p=0.003). The improvement in MR grade was more obvious in patients with functional aetiology. Although the actuarial survival was not significantly different between groups, freedom from re-admission for heart failure at 10 years was significantly lower in group II than in group I (23% vs 83%; p=0.002). Multivariate analysis demonstrated that independent predictors of heart failure were presence of mild-to-moderate MR (p=0.012, odds ratio (OR) 3.8) and left ventricular ejection fraction (p=0.004, OR 0.95). CONCLUSION: Despite the significant reduction after isolated AVR, preoperative mild-to-moderate MR is an independent risk factor impacting long-term functional outcome. Our results suggested that the concomitant mitral valve surgery for mild-to-moderate MR is warranted, especially in patients with reduced left ventricular function. Copyright 2009. Published by Elsevier B.V.
OBJECTIVE: The impact of untreated mild-to-moderate mitral regurgitation (MR) on patients undergoing isolated aortic valve replacement (AVR) is uncertain. The aim of this study is to investigate its long-term effects on outcomes. METHOD: We retrospectively reviewed 193 consecutive patients undergoing isolated AVR between 1993 and 2007. The mean age of the study group was 64+/-12 years, 59% were male and the mean preoperative ejection fraction was 59+/-12%. The pathologic aetiology and degree of MR was determined on preoperative echocardiogram. Patients were stratified into preoperative no/trivial MR (group I; n=134) versus mild-to-moderate MR (group II; n=59). The aetiology of MR in group II was either organic (n=35, 60%) or functional (n=24, 41%). Survival and functional outcome were compared between the two groups and analyses for predictors of adverse events were performed by the Cox proportional hazard model. RESULTS: Operative mortality was 2.6% (n=5). In group II, mean degree of MR significantly decreased from 2.1+/-0.3 to 1.6+/-0.8 during the late period (p=0.003). The improvement in MR grade was more obvious in patients with functional aetiology. Although the actuarial survival was not significantly different between groups, freedom from re-admission for heart failure at 10 years was significantly lower in group II than in group I (23% vs 83%; p=0.002). Multivariate analysis demonstrated that independent predictors of heart failure were presence of mild-to-moderate MR (p=0.012, odds ratio (OR) 3.8) and left ventricular ejection fraction (p=0.004, OR 0.95). CONCLUSION: Despite the significant reduction after isolated AVR, preoperative mild-to-moderate MR is an independent risk factor impacting long-term functional outcome. Our results suggested that the concomitant mitral valve surgery for mild-to-moderate MR is warranted, especially in patients with reduced left ventricular function. Copyright 2009. Published by Elsevier B.V.
Authors: Kirk R Hutchinson; Anuradha Guggilam; Mary J Cismowski; Maarten L Galantowicz; Thomas A West; James A Stewart; Xiaojin Zhang; Kevin C Lord; Pamela A Lucchesi Journal: J Appl Physiol (1985) Date: 2011-09-01
Authors: Asife Sahinarslan; Francesco Vecchio; Philip MacCarthy; Rafal Dworakowski; Ranjit Deshpande; Olaf Wendler; Mark Monaghan Journal: Acta Cardiol Sin Date: 2016-07 Impact factor: 2.672
Authors: David J Kaczorowski; John W Macarthur; Jessica Howard; Dale Kobrin; Alex Fairman; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2012-12-11 Impact factor: 5.209
Authors: Francis P Cheung; Cheng He; Philippa R Eaton; Jim Dimitriou; Andrew E Newcomb Journal: Ann Thorac Cardiovasc Surg Date: 2022-02-09 Impact factor: 1.889
Authors: Robert A Sorabella; Anna Olds; Halit Yerebakan; Dua Hassan; Michael A Borger; Michael Argenziano; Craig R Smith; Isaac George Journal: J Cardiothorac Surg Date: 2018-06-19 Impact factor: 1.637
Authors: Ilija Bilbija; Milos Matkovic; Marko Cubrilo; Nemanja Aleksic; Jelena Milin Lazovic; Jelena Cumic; Vladimir Tutus; Marko Jovanovic; Svetozar Putnik Journal: Int J Environ Res Public Health Date: 2020-10-08 Impact factor: 3.390